Table of Contents
Review
| The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma | |
| Xianxian Wu, et al. | 1-10 |
| Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma | |
| Meina Jiang, et al. | 1-10 |
Original Article
| LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA | |
| Mingwei Chen, et al. | 1-18 |
| NEDD9 promotes cancer stemness by recruiting myeloidderived suppressor cells via CXCL8 in esophageal squamous cell carcinoma | |
| Dongli Yue,et al. | 1-18 |
| BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees | |
| Laura Cortesi, et al. | 1-7 |
| Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids | |
| Lisi Zeng, et al. | 1-31 |
| A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma | |
| Qiujuan Huang, et al. | 1-15 |
| Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer | |
| Nanlin Hu, et al. | 1-11 |
| Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases | |
| Zhen Zhou, et al | 1-12 |
| L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma | |
| Xuan Zhao, et al. | 1-15 |
| Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver | |
| Xiangdong Ye, et al. | 1-17 |
| CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner | |
| Jun Ni, et al. | 1-18 |
| Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis | |
| Zhen Ni, et al. | 1-17 |
| Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma | |
| Meiting Chen, et al. | 1-8 |
OUR FRIENDS
